| Mr Robert Glenn Roten, LPT | |
|
6801 Indiana Ave, Lubbock, TX 79413-6109 | |
| (806) 785-7900 | |
| (806) 785-7909 |
| Full Name | Mr Robert Glenn Roten |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 29 Years |
| Location | 6801 Indiana Ave, Lubbock, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003865148 | NPI | - | NPPES |
| 8T2298 | Other | TX | BLUE CROSS/BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 1099638 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spectra Sports Medicine And Physical Therapy Lp | 5395723514 | 5 |
News Archive
NewLink Genetics Corporation announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process for a pivotal Phase 3 trial of its HyperAcute immunotherapy in pancreatic cancer. Pancreatic cancer is highly lethal and is currently an area of very significant unmet medical need. The SPA is a written agreement between NewLink as the trial sponsor and the FDA regarding the design, endpoints, and planned statistical analysis of a Phase 3 trial to be used in support of a Biologic License Application (BLA).
An interview with Jennifer Lee, Director of Market Access and Advocacy at Janssen UK, the pharmaceutical company of Johnson & Johnson, discussing the importance of innovation in the private sector and making new technologies available to the NHS.
Heart surgeons don't have to choose between taking a coronary-bypass patient off the popular anti-clotting drug clopidogrel (Plavix) after off-pump heart bypass surgery or having the patient bleed excessively in the days following surgery, according to a new study by researchers at Jefferson Medical College.
Representatives of health care marketing firms, patient advocacy groups and pharmaceutical companies this week are in Washington, D.C., to express support for loosening rules regarding drug companies' ability to market medications for off-label uses, the Wall Street Journal reports (Mundy, Wall Street Journal, 4/18).
› Verified 1 days ago
| Provider Name | Spectra Sports Medicine & Physical Therapy Lp |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1679522866 PECOS PAC ID: 5395723514 Enrollment ID: O20040713000537 |
News Archive
NewLink Genetics Corporation announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process for a pivotal Phase 3 trial of its HyperAcute immunotherapy in pancreatic cancer. Pancreatic cancer is highly lethal and is currently an area of very significant unmet medical need. The SPA is a written agreement between NewLink as the trial sponsor and the FDA regarding the design, endpoints, and planned statistical analysis of a Phase 3 trial to be used in support of a Biologic License Application (BLA).
An interview with Jennifer Lee, Director of Market Access and Advocacy at Janssen UK, the pharmaceutical company of Johnson & Johnson, discussing the importance of innovation in the private sector and making new technologies available to the NHS.
Heart surgeons don't have to choose between taking a coronary-bypass patient off the popular anti-clotting drug clopidogrel (Plavix) after off-pump heart bypass surgery or having the patient bleed excessively in the days following surgery, according to a new study by researchers at Jefferson Medical College.
Representatives of health care marketing firms, patient advocacy groups and pharmaceutical companies this week are in Washington, D.C., to express support for loosening rules regarding drug companies' ability to market medications for off-label uses, the Wall Street Journal reports (Mundy, Wall Street Journal, 4/18).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Robert Glenn Roten, LPT 6801 Indiana Ave, Lubbock, TX 79413-6109 Ph: (806) 785-7900 | Mr Robert Glenn Roten, LPT 6801 Indiana Ave, Lubbock, TX 79413-6109 Ph: (806) 785-7900 |
News Archive
NewLink Genetics Corporation announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process for a pivotal Phase 3 trial of its HyperAcute immunotherapy in pancreatic cancer. Pancreatic cancer is highly lethal and is currently an area of very significant unmet medical need. The SPA is a written agreement between NewLink as the trial sponsor and the FDA regarding the design, endpoints, and planned statistical analysis of a Phase 3 trial to be used in support of a Biologic License Application (BLA).
An interview with Jennifer Lee, Director of Market Access and Advocacy at Janssen UK, the pharmaceutical company of Johnson & Johnson, discussing the importance of innovation in the private sector and making new technologies available to the NHS.
Heart surgeons don't have to choose between taking a coronary-bypass patient off the popular anti-clotting drug clopidogrel (Plavix) after off-pump heart bypass surgery or having the patient bleed excessively in the days following surgery, according to a new study by researchers at Jefferson Medical College.
Representatives of health care marketing firms, patient advocacy groups and pharmaceutical companies this week are in Washington, D.C., to express support for loosening rules regarding drug companies' ability to market medications for off-label uses, the Wall Street Journal reports (Mundy, Wall Street Journal, 4/18).
› Verified 1 days ago
Mrs. Liesl Lynn Olson, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3223 S Loop 289, Ste 101, Lubbock, TX 79423 Phone: 806-740-3342 Fax: 806-740-3325 | |
Natalie Denise Steadman, ATC, LAT, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4507 7th St, Lubbock, TX 79416 Phone: 806-791-0316 Fax: 806-743-3518 | |
Jennifer Mounce, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4138 19th St, Lubbock, TX 79407 Phone: 806-771-8008 Fax: 806-771-8009 | |
Mr. Shane Edward Haas, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5606 Geneva Ave, Lubbock, TX 79413 Phone: 806-797-3805 Fax: 806-797-0140 | |
Mr. Charles Franklin Berry, PT, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1628 19th St, Lubbock, TX 79401 Phone: 806-766-1172 Fax: 806-766-1286 | |
Jodi Benham, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6202 82nd St, Lubbock, TX 79424 Phone: 806-687-8008 Fax: 806-687-8009 |